blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1285918

EP1285918 - C7 Ester substituted taxanes as antitumor agents [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  04.11.2005
Database last updated on 25.09.2024
Most recent event   Tooltip04.11.2005Application deemed to be withdrawnpublished on 21.12.2005  [2005/51]
Applicant(s)For all designated states
Florida State University Research Foundation, Inc.
100 Sliger Building, MC 2763 Tallahassee
Florida 32306-2763 / US
[N/P]
Former [2003/09]For all designated states
Florida State University Research Foundation, Inc.
100 Sliger Building, MC 2763
Tallahassee, Florida 32306-2763 / US
Inventor(s)01 / Holton, Robert A.
7125 Upland Glade
Tallahassee, Florida 32312 / US
 [2003/09]
Representative(s)Maiwald, Walter
Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2003/09]Maiwald, Walter, Dr. Dipl.-Chem.
Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3
80335 München / DE
Application number, filing date01118729.106.08.2001
[2003/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP1285918
Date:26.02.2003
Language:EN
[2003/09]
Search report(s)(Supplementary) European search report - dispatched on:EP12.11.2001
ClassificationIPC:C07D407/12, A61K31/335, A61P35/00
[2003/09]
CPC:
C07D305/14 (EP); A61P35/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2003/09]
TitleGerman:C7-Estersubstituierte Taxane als Antitumormittel[2003/09]
English:C7 Ester substituted taxanes as antitumor agents[2003/09]
French:Taxanes substitués par ester en C7 utilisés comme agents anticancereux[2003/09]
Examination procedure24.01.2002Amendment by applicant (claims and/or description)
13.08.2003Examination requested  [2003/42]
02.02.2005Despatch of a communication from the examining division (Time limit: M04)
14.06.2005Application deemed to be withdrawn, date of legal effect  [2005/51]
21.07.2005Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2005/51]
Fees paidRenewal fee
13.08.2003Renewal fee patent year 03
12.08.2004Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.08.200505   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]US5415869  (STRAUBINGER ROBERT M [US], et al) [X] 1-178 * claims 6,16,22 *;
 [X]WO9513053  (UNIV NEW YORK STATE RES FOUND [US]) [X] 1-178 * claim 8 *;
 [X]WO9744063  (NEUROMEDICA INC [US]) [X] 1-178 * claims 10,16-18 *;
 [X]WO9744026  (NEUROMEDICA INC [US]) [X] 1-178 * claims 6,12 *;
 [X]WO0001366  (NEOPHARM [US], et al) [X] 1-178 * claim 2 *;
 [X]WO0125223  (UNIV NEW YORK STATE RES FOUND [US]) [X] 1-178 * claim 5 *;
 [X]US2001002404  (WEBB NIGEL L [US], et al) [X] 1-178 * page 11 *;
 [E]WO0157013  (UNIV FLORIDA STATE RES FOUND [US]) [E] 1-178 * claims 1-123 *;
 [E]WO0157027  (UNIV FLORIDA STATE RES FOUND [US]) [E] 1-178 * claims 1-177 *;
 [X]  - B.-X. SHI ET AL., "Studies on the Quantitative Structure-activity Relationships of Paclitaxel Analogues", GOADENG XUEXIAO HUAXUE XUEBAO, (2000), vol. 21, no. 3, pages 401 - 406, XP000999959 [X] 1-178 * table 1 *
 [X]  - J. DUBOIS ET AL., "Fluorescent and Biotinylated Analogues of Docetaxel: Synthesis and Biological Evaluation", BIOORG. MED. CHEM., (1995), vol. 3, no. 10, pages 1357 - 1368, XP001022129 [X] 1-178 * Scheme I *

DOI:   http://dx.doi.org/10.1016/0968-0896(95)00115-W
 [X]  - J. DUBOIS ET AL., "Fluorescent and Biotinylated Analogues of Docetaxel: Synthesis and Biological Evaluation", BIOORG. MED. CHEM., (1995), vol. 3, no. 10, pages 1357 - 1368, XP000999888 [X] 1-178 * Scheme 1 *

DOI:   http://dx.doi.org/10.1016/0968-0896(95)00115-W
 [X]  - D. GUENARD ET AL., "Effects of the Hydrophobicity of Taxoids on their Interaction with Tubulin", BIOORG. MED. CHEM., (2000), vol. 8, no. 1, pages 145 - 156, XP001000434 [X] 1-178 * tables 1,4 *

DOI:   http://dx.doi.org/10.1016/S0968-0896(99)00279-5
 [X]  - F. GUERITTE-VOEGELEIN ET AL., "Relationships between the Structue of Taxol Analogues and Their Antimitotic Activity", J. MED. CHEM., (1991), vol. 34, no. 3, pages 992 - 998, XP000650581 [X] 1-178 * tables I,II *

DOI:   http://dx.doi.org/10.1021/jm00107a017
 [X]  - FERLINI, C. ET AL, "Antitumor activity of novel taxanes that act at the same time as cytotoxi agents and P-glycoprotein inhibitors", BR. J. CANCER (2000), 83(12), 1762-1768, XP001029698 [X] 1-178 * table 1 *

DOI:   http://dx.doi.org/10.1054/bjoc.2000.1500
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.